Women's Treatment: Residential Treatment for Co-Occurring SUD and SMI supports providers serving perinatal women in Ohio, funding integrated residential care to address mental health and substance use conditions.
Funder: Ohio Department of Mental Health and Addiction Services
Due Dates: November 18, 2026, 3 p.m. EDT (Questions) | November 25, 2026, 3 p.m. EDT (Applications)
Funding Amounts: Two awards of up to $250,000 each for December 7, 2026–September 30, 2027
Summary: Supports two Ohio regional residential treatment hubs integrating substance use, psychiatric, and medical care for perinatal women.
Key Information: Applicants must be 501(c)(3) or 501(c)(4) nonprofits or government entities with existing ASAM 3.5 and 3.7 services.
The Ohio Department of Behavioral Health (DBH), through its Bureau of Behavioral Health Treatment, Office of Treatment Services, is funding a pilot to establish two regional hubs for high-intensity, medically managed residential treatment. The hubs will serve women with moderate to severe co-occurring mental health and substance use conditions during pregnancy and up to 12 months after childbirth.
The program expands Ohio’s capacity to treat higher-acuity perinatal conditions through ASAM 3.5 and 3.7 co-occurring enhanced (COE) services and biomedical (BIO) services when needed. Priorities include early identification, integrated residential treatment, timely connections to obstetric, general, and pediatric healthcare, and coordinated transitions to other care levels. Services combine therapy, medication treatment, recovery supports, and partnerships supporting women and their children.